Identifying unilateral aldosterone-producing adenomas using published algorithms and imaging: a systematic review and meta-analysis [0.03%]
使用已发表的算法和影像学鉴别原发性醛固酮增多症中单侧 aldosterone 生产腺瘤的一篇系统评价和 Meta 分析
Elisabeth Ng,Stella May Gwini,Winston Zheng et al.
Elisabeth Ng et al.
Objective: Primary aldosteronism (PA) caused by a unilateral aldosterone-producing adrenal adenoma is surgically curable. However, radiologically visible adrenal adenomas are not necessarily functional. Adrenal vein sampl...
Reevaluating the use of metanephrine in adrenal vein sampling - a single centre retrospective study [0.03%]
肾上腺静脉取样中使用甲氧基肾上腺素的再评价-单中心回顾性研究
Hanna Remde,Mareike Schaupp,Carmina Teresa Fuss et al.
Hanna Remde et al.
Optimal treatment of primary aldosteronism (PA) requires precise subtyping, usually performed by adrenal vein sampling (AVS) using cortisol to assess selectivity. Circadian and stress-induced variability or cortisol co-secretion may limit i...
The Gender Incongruence module in the European Registries for Rare Endocrine & Bone Conditions (EuRREB): first results, current insights and future directions [0.03%]
欧洲罕见内分泌及骨病登记处(Gender Incongruence模块)：初步结果、当前见解和未来方向
Silvia Ciancia,Mariya Cherenko,Daniel Klink et al.
Silvia Ciancia et al.
Objective: Healthcare for transgender and gender diverse (TGD) adolescents varies across countries, therefore a specific module dedicated to gender incongruence (GI) within the European Registries for Rare Endocrine & Bon...
Clinical Heterogeneity and Imaging-driven Genetic Screening Priorities in Patients with Radiologically Suspected Primary Bilateral Macronodular Adrenal Hyperplasia [0.03%]
影像学怀疑原发性双侧肾上腺结节增生患者的临床异质性和影像驱动的基因筛查优先级
Huaijin Xu,Bing Li,Kang Chen et al.
Huaijin Xu et al.
Objective: To investigate the clinical spectrum, ARMC5 mutation distribution, and metabolic/cardiovascular risks in patients with radiologically suspected primary bilateral macronodular adrenal hyperplasia (PBMAH). ...
DNA Methylation in Kallmann Syndrome: Impacts on Neuronal Development and Spermatogenesis [0.03%]
Kallmann综合征的DNA甲基化变化及其对神经发育和精子发生的影响
Rongrong Wang,Xiaogang Li,Jingdi Zhang et al.
Rongrong Wang et al.
Objective: This study aims to comprehensively characterize the DNA methylation profile in the sperm of patients with Kallmann Syndrome (KS), providing new insights into the potential epigenetic mechanisms contributing to ...
Incidence and risk factors of venous thromboembolism in an adrenocortical carcinoma patient cohort [0.03%]
肾上腺皮质癌患者静脉血栓栓塞的发病情况及危险因素分析
Nienke Visser,Isabelle Holscher,C Willemien Menke-van der Houven van Oordt et al.
Nienke Visser et al.
Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine malignancy. Venous thromboembolic events (VTE) have been reported in ACC patients. ACC is often associated with endogenous hypercortisolism, which is linked to increased VTE ...
BUROSUMAB PREVENTS FURTHER HEIGHT DEFICIT IN TODDLERS AFFECTED BY XLH [0.03%]
布罗舒马斯特预防低血磷性佝偻病患儿身高的进一步缺失
Elisa Sala,Jugurtha Berkenou,Anya Rothenbuhler et al.
Elisa Sala et al.
Background: X-linked hypophosphatemia (XLH) is a rare disease caused by PHEX variants. Besides rickets, XLH leads to disproportionately short stature which develops during the first months of life. Burosumab afforded mini...
The Combined Diagnostic and Therapeutic Value of Ultrasound and X-ray Bone Age Index in Girls with Idiopathic Central Precocious Puberty [0.03%]
超声联合骨龄指数在女孩中枢性特发性性早熟诊断及治疗价值研究
Linli Kan,Deng He,Wensheng Yue
Linli Kan
Objectives: The objectives of this study are threefold: firstly, to evaluate the diagnostic utility of ultrasound in combination with radiographic bone age assessments for identifying idiopathic central precocious puberty...
Validation and Implementation of the Dutch PHPQoL for primary hyperparathyroidism [0.03%]
荷兰语PHPQoL的验证和原发性甲状旁腺功能亢进症的实施
Jaimie L H Zhang,Abbey Schepers,Jaap F Hamming et al.
Jaimie L H Zhang et al.
Background: Patients with primary hyperparathyroidism (PHPT) often present with nonspecific neuropsychological symptoms, which remain challenging to quantify. While parathyroidectomy (PTx) recently has been recommended fo...
Prevalence and risk factors of eligibility to anti-osteoporosis medication in a cohort of men ≥ 50 years and post-menopausal women who had already experienced bariatric surgery [0.03%]
一例队列≥50岁男性和绝经后女性胃旁路手术后抗骨质疏松药物适用率及其影响因素
Thomas Flament,Hélène Verkindt,Léa Mortain et al.
Thomas Flament et al.
The 2022 recommendations of the European Calcified Tissue Society (ECTS) suggest initiating anti-osteoporotic medication (AOM) in case of a T-score ≤ -2 and/or in case of a fragility fracture within less than 2 years. Therefore, this study...